(Progress of Disclosed Matter) Notice of Completion of Change in a Consolidated Subsidiary (Transfer of Share)

The Company announces that it has completed the transfer of the share of Ambry Genetics Corporation (Ambry Genetics) to Tempus AI, Inc. on February 3, 2025 (U.S. time). The transfer was disclosed by the Company on November 5, 2024, in “Notice Regarding Change in a Consolidated Subsidiary (Transfer of Share) and Recording of Profit from Discontinued Operation due to the Share Transfer.”

Following the completion of the transfer, Ambry Genetics has been excluded from the scope of consolidation of the Company. The impact of the share transfer on the Company’s consolidated financial results for the fiscal year ending March 31, 2025, was announced in “Notice Regarding Revision of Full-year Forecasts for Consolidated　Financial Results“ on November 5, 2024. The Company will promptly announce any matters that require disclosure in the future.